These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37982959)

  • 21. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study.
    Kato T; Yokomizo A; Matsumoto R; Tohi Y; Miyakawa J; Mitsuzuka K; Sasaki H; Inokuchi J; Matsumura M; Sakamoto S; Kinoshita H; Fukuhara H; Kamiya N; Kimura R; Nitta M; Okuno H; Akakura K; Kakehi Y; Sugimoto M
    Int J Urol; 2022 Nov; 29(11):1271-1278. PubMed ID: 35855586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
    Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
    Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
    Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
    Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and medical costs of non-small cell lung cancer patients according to the first-line treatment: An observational study using the Kyoto City Integrated Database.
    Shimamoto T; Tateyama Y; Kobayashi D; Yamamoto K; Takahashi Y; Ueshima H; Sasaki K; Nakayama T; Iwami T
    Thorac Cancer; 2023 Jun; 14(17):1574-1580. PubMed ID: 37082875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis.
    Cocco D; Shah C; Wei W; Wilkerson A; Grobmyer SR; Al-Hilli Z
    Br J Surg; 2022 Nov; 109(12):1293-1299. PubMed ID: 36066266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data.
    Miwa H; Takeshima T; Iwasaki K; Hiroi S
    J Med Econ; 2016 Nov; 19(11):1049-1055. PubMed ID: 27207316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study.
    DaCosta Byfield S; Buck PO; Blauer-Peterson C; Poston SA; DaCosta Byfield S; Buck PO; Blauer-Peterson C; Poston SA
    J Oncol Pract; 2016 Feb; 12(2):159-67. PubMed ID: 26395563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and Healthcare Cost Among Patients with Hip or Knee Osteoarthritis: A Cross-sectional Study Using a Real-world Claims Database in Japan Between 2013 and 2019.
    Ebata-Kogure N; Murakami A; Nozawa K; Fujii K; Lin Y; Ushida T; Kikuchi S
    Clin Drug Investig; 2020 Nov; 40(11):1071-1084. PubMed ID: 32965598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What affects the public healthcare costs of breast cancer in New Zealand?
    Lao C; Mondal M; Kuper-Hommel M; Campbell I; Lawrenson R
    Asia Pac J Clin Oncol; 2023 Aug; 19(4):482-492. PubMed ID: 36114604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.
    Park TS; Thomas SM; Rosenberger LH; Fayanju OM; Plichta JK; Blitzblau RC; Ong CT; Hyslop T; Hwang ES; Greenup RA
    Ann Surg Oncol; 2018 Oct; 25(10):3019-3029. PubMed ID: 29978365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Breast Cancer Pretreatment Nodal Burden and Disease Subtype on Axillary Surgical Management.
    Ng S; Sabel MS; Hughes TM; Chang AE; Dossett LA; Jeruss JS
    J Surg Res; 2021 May; 261():67-73. PubMed ID: 33421795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
    Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
    Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysis.
    Wattanakamolkul K; Nakayama Y
    J Med Econ; 2022; 25(1):870-879. PubMed ID: 35703058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Br J Surg; 2021 Sep; 108(9):1105-1111. PubMed ID: 34010418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial.
    Carcoforo P; Soliani G; Maestroni U; Donini A; Inderbitzin D; Hui TT; Lefor A; Avital I; Navarra G
    J Am Coll Surg; 2003 Mar; 196(3):365-9. PubMed ID: 12648685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW; McCready DR; Sawka CA; Goel V
    J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery: A Systematic Review.
    Wang T; Baskin AS; Dossett LA
    JAMA Surg; 2020 Aug; 155(8):759-770. PubMed ID: 32492121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social burden of three major diseases in Japan: A time trend and future projections using the comprehensive cost of illness method.
    Hirata K; Matsumoto K; Hatakeyama Y; Onishi R; Seto K; Hasegawa T
    PLoS One; 2023; 18(1):e0280311. PubMed ID: 36630469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.